CRMT(CRMT)
CRMT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $1.05B | $862M |
| Low | $1.02B | $832M |
| High | $1.09B | $893M |
| EBITDA Avg | $38M | $31M |
| Low | $36M | $30M |
| High | $39M | $32M |
| EBIT Avg | $33M | $27M |
| Low | $31M | $26M |
| High | $34M | $28M |
| Net Income Avg | $-13M | $-19M |
| Low | $-14M | $-20M |
| High | $-12M | $-18M |
| EPS Avg | $-1.56 | $-2.26 |
| Low | $-1.64 | $-2.36 |
| High | $-1.49 | $-2.16 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $251M | $260M | $289M | $216M | $214M | $209M | $223M |
| Low | $235M | $243M | $270M | $202M | $200M | $195M | $209M |
| High | $268M | $277M | $308M | $230M | $227M | $223M | $238M |
| EBITDA Avg | $9M | $9M | $10M | $8M | $8M | $7M | $8M |
| Low | $8M | $9M | $10M | $7M | $7M | $7M | $7M |
| High | $10M | $10M | $11M | $8M | $8M | $8M | $9M |
| EBIT Avg | $8M | $8M | $9M | $7M | $7M | $6M | $7M |
| Low | $7M | $8M | $8M | $6M | $6M | $6M | $6M |
| High | $8M | $9M | $10M | $7M | $7M | $7M | $7M |
| Net Income Avg | $-8M | $-788,826 | $913,377 | $-3M | $-7M | $-2M | $-7M |
| Low | $-8M | $-855,835 | $835,740 | $-3M | $-7M | $-2M | $-8M |
| High | $-7M | $-721,788 | $991,014 | $-3M | $-6M | $-2M | $-7M |
| EPS Avg | $-0.92 | $-0.10 | $0.11 | $-0.33 | $-0.82 | $-0.21 | $-0.90 |
| Low | $-0.99 | $-0.10 | $0.10 | $-0.36 | $-0.89 | $-0.23 | $-0.98 |
| High | $-0.84 | $-0.09 | $0.12 | $-0.30 | $-0.75 | $-0.19 | $-0.82 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |